Published Date: 06 Mar 2023
Srinagar: Government Medical College (GMC) Srinagar will have a new principal as the government announced on Thursday March 3...
Read Full NewsThe FDA has approved asundexian, the first factor XIa inhibitor indicated to reduce recurrent stroke after a noncardioembolic ischemic stroke or high-risk TIA, based on phase 3 OCEANIC-STROKE data.
An analysis of the PROSPECT trial reported that consistent use of transcutaneous afferent patterned stimulation was associated with improvement in underlying tremor severity in patients with essential tremor.
A study of deceased former NFL players estimated that nearly 75% had CTE neuropathology, while a phase 3 trial is evaluating whether F-18 FNT-PET imaging could help identify disease-associated patterns in living patients.
Odinachi Oguh, MD, movement disorder specialist at the Cleveland Clinic Lou Ruvo Center for Brain Health, shares clinical perspectives on biomarkers, aging, non-motor symptoms, and prodromal disease from the 2026 MDS Congress.
At a NeurologyLive Clinical Forum in New York, Mary Ann Piccone, MD, of Holy Name Medical Center, led a wide-ranging discussion among MS specialists on the limits of current high-efficacy therapies, the pipeline of emerging agents, and the gap between physician and patient treatment priorities.
Rezpegaldesleukin's Early Treg Signal in AD: Emma Guttman-Yassky, MD
Omalizumab Biosimilar CT-P39: Quality of Life Gains Precede CSU Control
1.
Newly identified T-cell subtype may explain treatment-resistant childhood leukemia
2.
Traces of bacteria inside brain tumors may affect tumor behavior
3.
Many Americans unaware of links between HPV and cancers, poll reveals
4.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
5.
Early Sugar Exposure and Cancer Risk; Melanoma Vaccine Win; 'Antifreeze' for CAR-T
1.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
2.
Molecular Classification of Refractory Anemia: A Comprehensive Review
3.
AI-Based Foundation Models for Rare Pathology Recognition
4.
National Blood Health Promotion Strategies: Evidence-Based Approaches for Improved Outcomes
5.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation